Victor L Villemagne,Christopher C Rowe
Victor L Villemagne
The progressive nature of neurodegeneration suggests an age-dependent process that ultimately leads to synaptic failure and neuronal damage in cortical areas of the brain critical for memory and higher mental functions. The increasing age o...
R S Osorio,V Berti,L Mosconi et al.
R S Osorio et al.
Early diagnosis of Alzheimer disease (AD) is one of the major challenges for the prevention of this dementia. The pathologic lesions associated with AD develop many years before the clinical manifestations of the disease become evident, dur...
Andrew B Newberg,Abass Alavi
Andrew B Newberg
One of the most important aspects for the evaluation of PET brain scans for research or clinical purposes is to be able to identify normal variants. This article reviews issues pertaining to the technical and neurophysiologic aspects of fun...
Mohsen Beheshti
Mohsen Beheshti
Value of (18)F NaF PET/CT in the Detection and Global Quantification of Cardiovascular Molecular Calcification as Part of the Atherosclerotic Process [0.03%]
18F钠氟化物正电子发射断层扫描/X线计算机体层成像检测并量化动脉粥样硬化心血管分子钙化的价值
Sandip Basu,Mohsen Beheshti,Abass Alavi
Sandip Basu
Detection of early ongoing cardiovascular molecular calcification and its quantification through (18)F-labeled sodium fluoride ((18)F NaF) PET/computed tomography (CT) imaging has been a recent addition to the diagnostic armamentarium of mo...
(18)F NaF PET/CT and Conventional Bone Scanning in Routine Clinical Practice: Comparative Analysis of Tracers, Clinical Acquisition Protocols, and Performance Indices [0.03%]
18F-NaF PET/CT和常规骨扫描在临床实践中的比较分析：示踪剂、临床采集协议和性能指标
Gad Abikhzer,John Kennedy,Ora Israel
Gad Abikhzer
Conventional planar and SPECT bone scintigraphy has long been used and familiarity with this tracer and imaging technique is excellent. (18)F NaF PET/CT represents an alternative tracer and imaging modality for the assessment of the skeleto...
(18)F NaF PET/CT in the Assessment of Metastatic Bone Disease: Comparison with Specific PET Tracers [0.03%]
18F钠氟化物PET/CT在转移性骨病评估中的应用：与特异性PET显像剂的对比研究
Mohsen Beheshti,Werner Langsteger
Mohsen Beheshti
The skeletal system is the third most common site of metastases after the lungs and liver, and 80% of all reported metastatic bone disease is in patients with breast and prostate cancer. At present there are an unprecedented number of novel...
Pediatric Bone Scanning: Clinical Indication of (18)F NaF PET/CT [0.03%]
儿童骨扫描：(18)F NaF PET/CT临床适应症研究
Laura A Drubach
Laura A Drubach
Skeletal imaging of children with fluorine-18 ((18)F) NaF harnesses the superior imaging characteristics of positron emission tomography (PET) and the improved biodistribution of the fluoride tracer compared with standard nuclear techniques...
Quantitative PET Imaging Using (18)F Sodium Fluoride in the Assessment of Metabolic Bone Diseases and the Monitoring of Their Response to Therapy [0.03%]
定量正电子发射断层扫描((18)F 钠氟化物在代谢性骨病评估及其疗效监测中的应用
Glen M Blake,Musib Siddique,Michelle L Frost et al.
Glen M Blake et al.
Studies of bone remodeling using bone biopsy and biochemical markers of bone turnover measured in serum and urine are important for investigating how new treatments for osteoporosis affect bone metabolism. Positron emission tomography with ...
Camila Mosci,Andrei Iagaru
Camila Mosci
Diagnostic imaging plays a major role in the evaluation of patients with malignant bone disease. (18)F-Labeled sodium fluoride ((18)F NaF) is a positron-emitting radiopharmaceutical with desirable characteristics (rapid blood clearance and ...